Home
Menu
LinkedIn
Logo: Adare Pharma Solutions
  • Quick Links
    • Learn About Our Precision Particle Fabrication® Technology
    • Explore Careers at Adare Pharma Solutions
    • Read About Our Latest News & Events
    • Knowledge Center

Patient-Centric Solutions

  • Overview
  • Taste Masking
  • Customized Release
  • Bioavailability Enhancement

Microbiome

Newsroom

Events

Knowledge Center

Technologies

  • Overview
  • AdvaTab®
  • Diffucaps®
  • Diffutab®
  • Microcaps®
  • Minitabs®
  • Optimμm®
  • Orbexa™
  • Parvulet™
  • Stratμm®
  • Unisun®

Manufacturing

  • Overview

Development Services

  • Overview
  • Precision Particle Fabrication®

Quality & Regulatory

Customer-Focused Support

About Us

  • Our Legacy
  • Our Leadership
  • Our People

Careers

Contact Us

Medical Inquiries

Meet With Us

Upcoming Events

 
  • Latest News
    • 09-22-20 THOMAS H. LEE PARTNERS AND FRAZIER HEALTHCARE PARTNERS ACQUIRE ADARE

      Boston, MA and Seattle, WA - September 22, 2020 Transaction includes specialty CDMO business, including pharmaceutical technology and microbiome... Learn More

    • 05-04-20 Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences

      Lawrenceville, NJ, and Lenexa, KS - May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual... Learn More

    • 01-13-20 Adare Pharmaceuticals and NLS Pharmaceutics collaborate to develop mazindol controlled release (CR) for the treatment of ADHD and narcolepsy

      Lawrenceville, NJ & Switzerland - January 13, 2020 Adare Pharmaceuticals, Inc. (Adare) and NLS Pharmaceutics Ltd. (NLS) announced today a collaboration... Learn More

    • 04-15-19 Adare acquires Egalet’s proprietary “Parvulet™” technology platform

      Princeton, NJ & Wayne, PA - April 15, 2019 Adare Pharmaceuticals, Inc. today announced that it has entered into an agreement with Egalet Corporation... Learn More

    • View all

Our global manufacturing sites meet all cGMP standards, and are optimized for the development and production of specialized oral-dose and injectable delivery systems. And through our in-house regulatory affairs team, Adare can take your product from molecule to market, quickly and efficiently.

— Giovanni Ortenzi, Pharmaceutical Development & Chief Technical Officer

Adare Pharma Solutions

CORPORATE OFFICES

Headquarters:
Princeton Pike Corporate Center
1200 Lenox Drive, Suite 100
Lawrenceville, NJ 08648
USA
+1 (609) 450-1312
597, Boul. Laurier
Mont-Saint-Hilaire, QC
Canada, J3H 6C4
+1 (450) 600-1414

MANUFACTURING

Via Martin Luther King, 13
20060 Pessano con Bornago (MI)
Italy
+39 02 954281
Via Molise, 16
20098 San Giuliano Milanese (MI)
Italy
+39 02 988981-200
Route de Bû
78550 Houdan
France
+33 (0)1 30 46 19 00

DEVELOPMENT & MANUFACTURING

845 Center Drive
Vandalia, Ohio 45377
USA
+1 (937) 898-9669
8006 Reeder Street
Lenexa, KS 66214
USA

©2021 Adare Pharma Solutions. All rights reserved

  • Privacy Policy
  • Terms & Conditions
  • Contact Us